| Aug 1 |
PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature
|
| Jul 24 |
PainReform files patent covering manufacturing process for post-operative pain control product
|
| Jul 24 |
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing
|
| Jun 26 |
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
|
| May 31 |
PainReform receives Nasdaq minimum bid price notification
|
| May 31 |
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
|
